Anzeige
+++Der 9,5 Mio. € Kupferfehler des Marktes Und solche Fehler korrigieren sich schnell+++
EQS-News

VARON Recommends Winter Respiratory Care as Germany Faces Seasonal Health Challenges 03.03.2026, 01:15 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: Varon oxygen concentrator / Key word(s): Miscellaneous/ESG
VARON Recommends Winter Respiratory Care as Germany Faces Seasonal Health Challenges

03.03.2026 / 01:15 CET/CEST
The issuer is solely responsible for the content of this announcement.


BERLIN, March 3, 2026 /PRNewswire/ -- Although winter is coming to an end, the cold weather usually lasts for a couple of weeks across Germany, VARON continue to emphasize respiratory protection and heart health awareness. Cold temperatures, dry indoor heating, and seasonal viruses can increase breathing difficulty for seniors and individuals managing chronic respiratory or cardiovascular conditions. During winter months, maintaining stable oxygen levels and comfortable breathing environments becomes especially important for daily wellness.

Varon Oxygen Concentrator

Healthcare experts note that winter air is typically drier, which may irritate airways and reduce natural respiratory comfort. Reduced outdoor activity during colder months can also impact circulation and overall oxygen intake.

"Accessible respiratory support at home can help families maintain better quality of life during winter months," said the company's CEO.

Daily Winter Health Protection Recommendations

Healthcare specialists recommend several habits to help support respiratory wellness during winter:

  • Maintain balanced indoor humidity to help protect airway moisture
  • Stay hydrated to support lung and respiratory system function
  • Perform light indoor exercises to promote circulation
  • Monitor breathing comfort during sleep and rest periods
  • Avoid long exposure to cold air without adequate protection

These practices help reduce respiratory strain while supporting overall heart and lung wellness throughout the winter season.

Home Oxygen Therapy for Winter Comfort

For households seeking additional respiratory support, VARON recommends its home respiratory wellness technology as a supportive solution for winter breathing comfort. The VARON VH-3 Pro oxygen concentrator for home use provides continuous oxygen therapy designed for long-term daily operation.

The device supports winter wellness by delivering stable oxygen flow for indoor environments where heating systems can reduce air moisture. Its quiet performance helps users maintain restful sleep environments during long winter nights. Energy-efficient operation also supports extended use for seniors who require consistent breathing comfort throughout the day.

The VH-3 Pro home oxygen concentrator also features intelligent oxygen humidification technology, helping reduce dryness irritation often caused by winter heating systems. Users can operate the device quietly during work, study, or sleep routines thanks to its low noise performance.

Commitment to Respiratory Wellness

VARON continues expanding accessible respiratory wellness solutions for German households facing seasonal health challenges. The company aims to support modern home health management through smart oxygen therapy technology.

About VARON
VARON develops advanced respiratory wellness technology focused on intelligent oxygen therapy solutions for modern healthcare lifestyles.

Media Contact
Company: VARON
Email: support@varoninc.de 
Website: https://varoninc.de/

Logo - https://mma.prnewswire.com/media/2660036/5830533/varon_oxygen_concentrator_logo_Logo.jpg

Cision View original content:https://www.prnewswire.com/de/pressemitteilungen/varon-recommends-winter-respiratory-care-as-germany-faces-seasonal-health-challenges-302701705.html

rt.gif?NewsItemId=EN98918&Transmission_Id=202603021910PR_NEWS_EURO_ND__EN98918&DateId=20260302


03.03.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2284194  03.03.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Weitere News

3:02 Uhr • Artikel • dpa

Gestern 21:05 Uhr • Artikel • dpa-AFX

Gestern 21:05 Uhr • Artikel • dpa-AFX

Gestern 20:58 Uhr • Artikel • dpa-AFX

Gestern 20:49 Uhr • Artikel • dpa-AFX

Gestern 20:45 Uhr • Artikel • dpa-AFX

Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer